Recent News

• 03.19.2026 - DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
• 03.11.2026 - DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
• 03.10.2026 - Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health
• 12.10.2025 - Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members
• 12.04.2025 - Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
• 11.24.2025 - DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
• 11.13.2025 - DarioHealth Reports Third Quarter 2025 Financial and Operating Results
• 11.12.2025 - DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform

Recent Filings

• 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.02.2026 - 8-K Current report
• 01.29.2026 - 8-K Current report
• 01.08.2026 - EFFECT Notice of Effectiveness
• 12.29.2025 - S-3/A Registration statement under Securities Act of 1933
• 12.22.2025 - DEF 14A Other definitive proxy statements
• 12.22.2025 - ARS Annual Report to Security Holders
• 12.16.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 12.11.2025 - PRE 14A Other preliminary proxy statements
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors